Member Info for ratcliffewriter

Placings are tonraise money when there is no or insufficient income stream, usually at a discount (sometime substantial) to the current share price. See regular RNSs from Val for placings at steadily reducing prices, often preceeded by vague and highly optimistic outpourings from other RNSs.

They are not consolidations. Consolidations are performed when the share prices goes below the nominal value of each share and causes an artificial spike in the share value to allow the company to continue issuing shares (no income stream etc etc) and are usually followed by a decline in the new share price, causing even more losses for anyone suckered in by the pre consolidation hype.

For detail, look at the VAL sp and the consolidations. Choice of 3 to examine.

Each consolidation has reduced the value of any shareholding by 125 times.

Watch and wait.

.....and zilch by way of income. A shameless exercise in polishing that which rhymes with Richard the third.

Worth reading the comments below that say 'The future, whether long, medium or even short term has never been brighter' and 'The Pink Nick/Porky combo is now desperate to halt momentum - sadly (for them), it is a lost cause.'

Make a copy of those quotes for reference over the forthcoming weeks and months, and also read the RNSs, not the press releases or off-the-cuff comments from board members.

Popcorn time looming....

Some amazing 'facts' (pmsl) we've had revealed lately here. NDAs don't allow anything to be kept secret and now patents aren't worth the paper they're written on. How altruistic to reveal the truth that nobody else knew...

...and a late declared 1.2 million. Presumably a buy (or to keep certain quarters happy, undoubtedly a sell).

Under an NDA you could (I presume) be kept abreast of the progress of a trial prior to it being complete, checked, and signed off for public release - otherwise you get Knowlesi-itis if you expect every step with every patient to be released by RNS, causing potential wild swings in the share price to the delight of the traders and wasting a lot of time at the business end of things. You could also have talks on the potential intricacies of a deal or buyout, and only when it became 'formal offer' time would it need to be released. A bit like the difference between someone viewing your house versus them making an actual offer.

Otherwise what would be the point of ever having any NDA at all?

Also worth bearing in mind that that unless Vulpes and Redmile are in agreement with anything like a takeover then it's going nowhere. But as ever, let's just watch and wait. Hypothesising only tends to lead down rabbit holes. Che sara sara....

So what's the point of an NDA? You're starting to sound a bit like Knowlesi who had the idea that because he had bought a share he had some right to be told everything that was going on in the company. There will be material covered by an NDA which is approaching a conclusion but not at a stage where it can be presented as complete for example, or different options of in which direction the company may go which are not for public consumption but would be relevant to discussions. Can you imagine the alternative?

'Results are looking good.'

'Can we see the detail of progress so far?'

'Errr...no.'

'How about if we want to make an offer for a product - what sort of terms are you considering?'

'Not telling you.'

NDAs are there for a purpose and I trust are going to bear fruit. Once the fruit is ripe, then it becomes something for the public domain.

Fat finger moment - should have read 'not much point in having an NDA and then having to make public everything discussed under it. It would just be a "DA" then, which would make confidential negotiations pretty useless.'

Not much point in having

'Did you know that pumping a listed company while selling its shares is illegal in the UK?'

Better tell your crew then hadn't you?

Scinv is also very similar to various previous visitors here whonwould have you believe they are on first name terms with your stockbroker and know all your holdings, buys and sells - and naturally if you buy or hold you're a mug because they're making loadsamoney elsewhere and you're not) and if you sell you're a dirty hypocritical trader, but then it takes one to spot one.

It's not been a good day for you has it scinv?

Easy to buy - but only if you're very rich I trust.

I presume Genmab are happy with results so far on their glymab venture.

It turns out admin removed a thread for reasons not connected with my post, so away from the bickering I would suggest anyone serious about looking at Val have a read of the Ambrose-related recent RNS -

It's worth reading this paragraph carefully - 'The initial £6 million milestones are payable in cash or the equivalent value in new ordinary shares in Ambrose with the issue price determined by the latest issue of shares in Ambrose, at the discretion of Ambrose. Payment of milestones in cash is subject to Ambrose raising capital in due course.'

Obviously there is no milestone at the start of this journey, so no money until some form of clinical or commercial action, and clinical will no doubt precede anything commercial - a realistic number of patients in trial in a clinic with more credibility than one in Tblisi would be a start - and it then says that Ambrose haven't raised any cash yet, so can pay in shares at their discretion (Val would have no say in whether they got crisp tenners or soggy confetti) and what use would shares be in a company that can't raise cash?

Still no investment case here imo, but happy to watch. There looks to be a large gap between the present moment and any event that might deliver funding, and even then it might just be a bunch of shares of dubious value.

If money had been paid or was imminent and certain I'm pretty sure the RNS would have stated it loud and clear. The fact it didn't give any actual timeline I find concerning.

I wonder which part of drilling down into a direct quote from a company RNS is a breach of posting rules warranting removal?

We can speculate all day long - it could be anything from a proposed buyout for squillions of pounds to a decision to abandon the science and set up a contract cleaning company. As ever I'd suggest we wait and see. After all, it's not long to wait.

'The initial £6 million milestones are payable in cash or the equivalent value' and 'More later including royalty payments' - when you say 'later', what timescale is that, and what conditions need to be fulfilled to trigger any milestones?

When does the 16 million arrive then?

The consolidations were 125:1 not 100:1, meaning an initial stake of 10,000 quid would become a pound at 100:1 times two, and 64p at 125:1 times two, assuming there was no reduction in value in the share price after consolidation. This is presumably why the board always take their bonuses in cash.